September 26, 2005
(Rockfield, MD, September 26) — Scientists from J. Craig Venter Institute, Ludwig Institute for Cancer Research, and The Johns Hopkins University School of Medicine identified three novel mutations in two receptor tyrosine kinases in glioblastoma tumors using high throughput sequencing.
September 18, 2005
The successful candidate will be a world-recognized leader in a field of research that is strongly linked to human cancer. The candidate must be willing to contribute actively to LICR’s global research programs and have strong administrative and leadership skills. The Branch Director will report to the Institute’s President and Scientific Directorate.